Recent NEC lawsuits have shaken the infant formula industry, raising concerns over the future of preterm formula availability ...

The company primarily focuses on its drug candidate, IBP-9414, that is designed to reduce the incidence of necrotizing enterocolitis (NEC) and improve sustained feeding tolerance (SFT) in prematurely ...

“Between 2018 and 2022, there were no differences in rates of mortality for Black compared to white infants, but Black infants still experienced higher rates of necrotizing enterocolitis and ...